Read, Watch or Listen

Mark Cuban has given President Trump's planned direct-to-consumer online drug store, TrumpRx.gov, a "B" grade. The venture aims to bypass Pharmacy Benefit Managers (PBMs) by allowing consumers to buy prescription drugs directly from manufacturers. While Cuban sees potential benefits for patients and his own Cost Plus Drugs company, he criticizes the plan for not significantly impacting PBM stock prices, suggesting the system may still favor intermediaries. Pfizer has committed to offering drugs at reduced rates on the site, which is expected to launch in 2026.

Prepared by Christopher Adams and reviewed by editorial team.